BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 18822830)

  • 1. Substance use disorders in adolescents with attention-deficit/hyperactivity disorder.
    Bukstein O
    Adolesc Med State Art Rev; 2008 Aug; 19(2):242-53, viii. PubMed ID: 18822830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults.
    Asherson P
    Expert Rev Neurother; 2005 Jul; 5(4):525-39. PubMed ID: 16026236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders.
    Bukstein OG
    Expert Rev Neurother; 2006 Apr; 6(4):541-9. PubMed ID: 16623653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult ADHD and substance abuse: diagnostic and treatment issues.
    Kalbag AS; Levin FR
    Subst Use Misuse; 2005; 40(13-14):1955-81, 2043-8. PubMed ID: 16282088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention deficit hyperactivity disorder in prison: a treatment protocol.
    Appelbaum KL
    J Am Acad Psychiatry Law; 2009; 37(1):45-9. PubMed ID: 19297632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-deficit/hyperactivity disorder in adolescent males.
    Schubiner H; Robin AL; Young J
    Adolesc Med; 2003 Oct; 14(3):663-76, vii-viii. PubMed ID: 15122167
    [No Abstract]   [Full Text] [Related]  

  • 14. [The significance of attention-deficit hyperactivity disorder for the future of the child and the young].
    Penttilä J; Rintahaka P; Kaltiala-Heino R
    Duodecim; 2011; 127(14):1433-9. PubMed ID: 21888044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conduct disorder in referred children and adolescents: clinical and therapeutic issues.
    Masi G; Milone A; Manfredi A; Pari C; Paziente A; Millepiedi S
    Compr Psychiatry; 2008; 49(2):146-53. PubMed ID: 18243886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of adult attention-deficit/hyperactivity disorder.
    Post RE; Kurlansik SL
    Am Fam Physician; 2012 May; 85(9):890-6. PubMed ID: 22612184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.
    Young J
    Adolesc Med State Art Rev; 2008 Aug; 19(2):216-28, vii. PubMed ID: 18822828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention deficit/hyperactivity disorder: complexities and controversies.
    Schonwald A; Lechner E
    Curr Opin Pediatr; 2006 Apr; 18(2):189-95. PubMed ID: 16601502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of attention deficit hyperactivity disorder in adults.
    Greenfield B; Hechman L
    Expert Rev Neurother; 2005 Jan; 5(1):107-21. PubMed ID: 15853481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.